Company
Headquarters: Shanghai, China
CEO: Mr. Duane Lee
TW$1.61 Billion
TWD as of Jan. 1, 2025
US$49.0 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Cowealth Medical Holding Co., Ltd. operates as a medical distribution company primarily in the diagnostic clinical laboratory field in Greater China market. It also specializes in reagent, cross-strait hospital department cooperation, and radiotherapy fields. In addition, the company undertakes the Summit project, which consolidates outside procurement of diagnostic reagents at prices as before; and provides related with related logistics management services. The company was founded in 1997 and is based in Shanghai, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Cowealth Medical Holding Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 4745 wb_incandescent